Regulatory package submission for Her-Vaxx in Hong Kong
Filed with ASX · · 2 pages · English
Story so far
Earlier from Imugene
- Imugene Announces Successful Capital Raising
- Manufacturing Update
- Partnership to Develop Mimotope Immuno-Oncology Platform
- Imugene key HER-Vaxx patent granted in Europe
Later from Imugene
- Imugene Receives Institutional Review Board Approval
- Imugene Receives Approval to Start Gastric Cancer Study
- Imugene Final Cancer Vaccine Doses Delivered to GMP Depot
- Imugene successfully completes preclinical animal studies
- Imugene receives $1.3m R&D Tax Refund
Follow Imugene into a list and get an email when it puts out news.
Follow Imugene